PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Life Sciences, College of Health, Medicine and Life Sciences, Brunel University London, Uxbridge UB8 3PH, UK.\', \'Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism (WISDEM), University Hospitals Coventry and Warwickshire NHS Trust, Coventry CV2 2DX, UK.\', \'Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK.\', \'Laboratory of Clinical Virology, Medical School, University of Crete, 71409 Heraklion, Greece.\', \'Mount Vernon Cancer Centre, Middlesex HA6 2RN, UK.\', \'National Heart and Lung Institute, Imperial College London, London SW3 6LY, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3892/ijmm.2021.489764
?:hasPublicationType
?:journal
  • International journal of molecular medicine
is ?:pmid of
?:pmid
?:pmid
  • 33649798
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.992
?:rankingScore_hIndex
  • 78
is ?:relation_isRelatedTo_publication of
?:title
  • COVID‑19 and SARS‑CoV‑2 host cell entry mediators: Expression profiling of TMRSS4 in health and disease.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all